查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362934

细胞培养市场规模、份额和趋势分析报告：2023-2030 年按产品、应用、地区和细分市场分類的趋势

Cell Culture Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Diagnostics, Cell & Gene Therapy), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

细胞培养市场的成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球细胞培养市场规模将达到390.9亿美元，2023年至2030年年复合成长率为11.32%。

新型三维细胞培养技术以及生物製药开发、疫苗生产不断增长的需求以及全球对先进治疗药物不断增长的需求预计将在预测期内推动市场发展。 COVID-19大流行加速了疫苗开发活动，特别是在新型 mRNA 和 DNA 疫苗领域。大规模疫苗生产对使用细胞培养技术生产的载体产生了高的需求。例如，2023年2月，SK Bioscience宣布其首款基于细胞培养的四价流感疫苗SKYCellflu已在南美洲由智利公共卫生研究所（Instituto de Salud Publica de Chile，ISP）正式批准宣布。

此外，疫苗开发需要使用基于细胞的测定进行多个表达分析、品管和安全测试步骤。因此，近年来，细胞培养产品在此类应用中的使用需求量很大。此外，感染疾病发病率的增加、对疾病爆发预防的日益关注以及对疫苗技术的高研发投资预计将吸引疫苗生产并促进市场成长。在生物製药领域，培养哺乳动物细胞的能力使得大量生产复杂的蛋白质为基础的药物成为可能。

这提高了生物製药行业的效率、降低了成本并改善了品管。此外，高产细胞株的推出和培养条件的最佳化也有助于提高生产力和可扩展性。例如，2023年6月，Matica Bio在BIO国际大会上宣布了MatiMax细胞株。此外，一些公司正在采取市场扩张等策略性配合措施，这有助于市场成长。例如，2021 年 3 月，赛默飞世尔科技宣布了一项扩张计划，到 2022 年将投资 6 亿美元的资本支出。该公司位于苏格兰、佛罗里达和纽约的细胞培养基和製程流体工厂提高了 Gibco 细胞培养基、製程流体和补充剂的生产能力。这些新兴市场的发展预计将在预测期内推动市场成长。

细胞培养市场报告亮点

  • 由于製药和生物製药公司生产单株抗体、疫苗、细胞和基因治疗等先进生物製药的研发费用增加，消耗品市场在2022年占据最大份额，为57.44%。
  • 生物製药生产领域占比最大，2022年为32.15%。生物技术领域预计将扩大，从而推动预测期内对细胞培养用品和设备的需求。
  • 2022 年，北美市场占据主导地位，份额为 35.90%。这一巨大份额归因于该地区完善的製药和生物技术部门以及美国越来越多地采用先进技术的解决方案。此外，细胞培养技术的市场也很大，因为多所大学正在该地区进行大规模的细胞治疗研究。
  • 由于人们对细胞和基因疗法的认识不断提高、科学以及再生医学和癌症免疫疗法等新兴疗法的迅速采用，预计亚太地区在预测期内将以 13.79% 的年复合成长率增长最快。

目录

第1章调查方法和范围

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第4章产品经营分析

  • 细胞培养市场：产品波动分析
  • 消耗品
    • 2018-2030年全球消耗品市场
    • 媒体
    • 血清
    • 试剂
  • 装置
    • 2018-2030年全球设备市场
    • 文化体系
    • 培养箱
    • 离心机
    • 冷冻储存装置
    • 生物安全设备
    • 移液器设备

第5章商业分析的应用

  • 细胞培养市场：应用变化分析
  • 生物製药生产
  • 药物开发
  • 诊断
  • 组织培养与工程
  • 细胞和基因治疗
  • 毒性试验
  • 其他用途

第6章区域业务分析

  • 2022年及2030年细胞培养市场占有率（按地区）
  • 北美洲
    • 北美细胞培养市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲细胞培养市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太细胞培养市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲细胞培养市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 中东和非洲细胞培养市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率分析
  • 公司简介/名单
    • Sartorius AG
    • Danaher
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Corning Inc.
    • Avantor Inc.
    • BD
    • Eppendorf SE
    • Bio-Techne
    • PromoCell GmbH
Product Code: 978-1-68038-536-6

Cell Culture Market Growth & Trends:

The global cell culture market size is expected to reach USD 39.09 billion by 2030 and is expected to grow at a CAGR of 11.32% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development, vaccine production, and the rising global demand for advanced therapy medicinal products are expected to drive the market during the forecast period. The COVID-19 pandemic has increased vaccine development activities, especially in the novel mRNA and DNA vaccines space. Vaccine production at a large scale generates a high demand for vectors produced using cell culture techniques. For instance, in February 2023, SK Bioscience announced that its first cell culture-based quadrivalent influenza vaccine, SKYCellflu, was officially licensed in South America by Instituto de Salud Publica de Chile (Institute of Public Health, ISP).

Furthermore, vaccine development requires several expression analyses, quality control, and safety testing procedures, which use cell-based assays. As a result, the usage of cell culture products for such applications has witnessed high demand in recent years. In addition, with an increase in the incidence of infectious diseases, a rise in focus on prevention of disease outbreaks, and high R&D investments in vaccine technologies, vaccine production is projected to gain traction and boost market growth.Moreover, cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells.

This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention.Furthermore, several companies are engaged in strategic initiatives, such as market expansion, which can be attributed to market growth. For instance, in March 2021, Thermo Fisher Scientific, Inc. announced its expansion plans by investing USD 600 million into capital investments through 2022. Its cell culture media and process liquid sites in Scotland, Florida, and New York increased the production capacity of Gibco cell culture media, process liquids, and supplements. Such developments are expected to propel the market growth over the forecast period.

Cell Culture Market Report Highlights:

  • The consumables product segment accounted for the largest share of 57.44% in 2022 due to increased R&D spending by pharmaceutical & biopharmaceutical businesses to produce advanced biopharmaceuticals, such as monoclonal antibodies, vaccines, and cell & gene therapies
  • The biopharmaceutical production segment accounted for the largest share of 32.15% in 2022. The biotechnology sector is anticipated to expand, fueling demand for cell culture supplies and instruments over the forecast period
  • North America dominated the market with a share of 35.90% in 2022. The large share can be attributed to the region's well-established pharmaceutical & biotech sectors and higher adoption of technologically advanced solutions in the U.S. In addition, there is a large market for cell culture technologies in the region due to the extensive cell therapy research efforts undertaken by several universities
  • Asia Pacific is projected to expand at the fastest CAGR of 13.79% over the forecast period due to the rising awareness regarding cell and gene therapies, and the rapid adoption of scientific technologies and emerging therapeutics, such as regenerative medicines and cancer immunotherapies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion in the scope of cell culture technology
      • 3.2.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
      • 3.2.1.3. Growth in demand for serum-free, specialty, and customized media
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent process control in cell culture techniques
      • 3.2.2.2. Scalability issues with culturing methods
      • 3.2.2.3. Ethical concerns regarding use of animals
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Cell Culture Market: Product Movement Analysis
  • 4.2. Consumables
    • 4.2.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 4.2.2. Media
      • 4.2.2.1. Global media market, 2018 - 2030 (USD million)
      • 4.2.2.2. Serum-free media
      • 4.2.2.2.1. Global serum-free media market, 2018 - 2030 (USD million)
      • 4.2.2.2.2. CHO media
      • 4.2.2.2.2.1. Global CHO media market, 2018 - 2030 (USD million)
      • 4.2.2.2.3. BHK medium
      • 4.2.2.2.3.1. Global BHK medium market, 2018 - 2030 (USD million)
      • 4.2.2.2.4. Vero medium
      • 4.2.2.2.4.1. Global Vero medium market, 2018 - 2030 (USD million)
      • 4.2.2.2.5. HEK 293 Media
      • 4.2.2.2.5.1. Global HEK 293 media market, 2018 - 2030 (USD million)
      • 4.2.2.2.6. Other serum-free media
      • 4.2.2.2.6.1. Global other serum-free media market, 2018 - 2030 (USD million)
      • 4.2.2.3. Classical media
      • 4.2.2.3.1. Global classical media market, 2018 - 2030 (USD million)
      • 4.2.2.4. Stem cell culture media
      • 4.2.2.4.1. Global stem cell culture media market, 2018 - 2030 (USD million)
      • 4.2.2.5. Specialty media
      • 4.2.2.5.1. Global specialty media market, 2018 - 2030 (USD million)
      • 4.2.2.6. Chemically defined media
      • 4.2.2.6.1. Global chemically defined media market, 2018 - 2030 (USD million)
      • 4.2.2.7. Other cell culture media
      • 4.2.2.7.1. Global other cell culture media market, 2018 - 2030 (USD million)
    • 4.2.3. Sera
      • 4.2.3.1. Global sera market, 2018 - 2030 (USD million)
      • 4.2.3.2. Fetal bovine serum
      • 4.2.3.2.1. Global fetal bovine serum market, 2018 - 2030 (USD million)
      • 4.2.3.3. Others
      • 4.2.3.3.1. Global others market, 2018 - 2030 (USD million)
    • 4.2.4. Reagents
      • 4.2.4.1. Global reagents market, 2018 - 2030 (USD million)
      • 4.2.4.2. Albumin
      • 4.2.4.2.1. Global albumin market, 2018 - 2030 (USD million)
      • 4.2.4.3. Others
      • 4.2.4.3.1. Global others market, 2018 - 2030 (USD million)
  • 4.3. Instruments
    • 4.3.1. Global instruments market, 2018 - 2030 (USD million)
    • 4.3.2. Culture systems
      • 4.3.2.1. Global culture systems market, 2018 - 2030 (USD million)
    • 4.3.3. Incubators
      • 4.3.3.1. Global incubators market, 2018 - 2030 (USD million)
    • 4.3.4. Centrifuges
      • 4.3.4.1. Global centrifuges market, 2018 - 2030 (USD million)
    • 4.3.5. Cryostorage equipment
      • 4.3.5.1. Global cryostorage equipment market, 2018 - 2030 (USD million)
    • 4.3.6. Biosafety equipment
      • 4.3.6.1. Global biosafety equipment market, 2018 - 2030 (USD million)
    • 4.3.7. Pipetting instruments
      • 4.3.7.1. Global pipetting instruments market, 2018 - 2030 (USD million)

Chapter 5. Application Business Analysis

  • 5.1. Cell Culture Market: Application Movement Analysis
  • 5.2. Biopharmaceutical Production
    • 5.2.1. Global Biopharmaceutical Production Market, 2018 - 2030 (USD Million)
    • 5.2.2. Monoclonal antibodies
      • 5.2.2.1. Monoclonal antibodies market, 2018 - 2030 (USD million)
    • 5.2.3. Vaccines production
      • 5.2.3.1. Global vaccines production market, 2018 - 2030 (USD million)
    • 5.2.4. Other therapeutic proteins
      • 5.2.4.1. Global other therapeutic proteins market, 2018 - 2030 (USD million)
  • 5.3. Drug Development
    • 5.3.1. Global drug development market, 2018 - 2030 (USD Million)
  • 5.4. Diagnostics
    • 5.4.1. Global diagnostics market, 2018 - 2030 (USD Million)
  • 5.5. Tissue Culture & Engineering
    • 5.5.1. Global tissue culture & engineering, 2018 - 2030 (USD Million)
  • 5.6. Cell & Gene Therapy
    • 5.6.1. Global cell and gene therapy market, 2018 - 2030 (USD million)
  • 5.7. Toxicity Testing
    • 5.7.1. Global toxicity testing market, 2018 - 2030 (USD million)
  • 5.8. Other Applications
    • 5.8.1. Global other applications market, 2018 - 2030 (USD million)

Chapter 6. Regional Business Analysis

  • 6.1. Cell Culture Market Share By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Mexico Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Argentina Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Cell Culture Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Sartorius AG
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Danaher
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Corning Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Avantor Inc.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. BD
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Eppendorf SE
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Bio-Techne
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. PromoCell GmbH
      • 7.4.10.1. Overview
      • 7.4.10.2. Product Benchmarking
      • 7.4.10.3. Strategic Initiatives

List of Tables

  • Table 1 Global cell culture market, by region, 2018 - 2030 (USD Million)
  • Table 2 Global cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 13 UK cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 14 Germany cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 15 Germany cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 16 France cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 17 France cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 22 Denmark cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 24 Sweden cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 26 Norway cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific cell culture market, by application, 2018 - 2030 (USD Millon)
  • Table 30 Japan cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 31 Japan cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 32 China cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 33 China cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 34 India cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 35 India cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 36 Australia cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 37 Australia cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 38 South Korea cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 39 South Korea cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 40 Thailand cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 41 Thailand cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 42 Latin America cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 43 Latin America cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 44 Brazil cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 45 Brazil cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 46 Mexico cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 47 Mexico cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 48 Argentina cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 49 Argentina cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 50 Middle East & Africa cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 52 South Africa cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 53 South Africa cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 54 Saudi Arabia cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 55 Saudi Arabia cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 56 UAE cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 57 UAE cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 58 Kuwait cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 59 Kuwait cell culture market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Cell culture market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Life science tools market value, 2022 (USD billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 Number of biologics approved by the U.S. FDA each year from 2015 to 2022
  • Fig. 18 PESTEL analysis
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 Cell culture market: Product outlook & key takeaways
  • Fig. 21 Cell culture market: Product movement analysis
  • Fig. 22 Global consumables market, 2018 - 2030 (USD Million)
  • Fig. 23 Global media market, 2018 - 2030 (USD Million)
  • Fig. 24 Global serum-free media market, 2018 - 2030 (USD Million)
  • Fig. 25 Global CHO media market, 2018 - 2030 (USD Million)
  • Fig. 26 Global BHK medium market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Vero medium market, 2018 - 2030 (USD Million)
  • Fig. 28 Global HEK 293 media market, 2018 - 2030 (USD Million)
  • Fig. 29 Global other serum-free media market, 2018 - 2030 (USD Million)
  • Fig. 30 Global classical media market, 2018 - 2030 (USD Million)
  • Fig. 31 Global stem cell culture media market, 2018 - 2030 (USD Million)
  • Fig. 32 Global specialty media market, 2018 - 2030 (USD Million)
  • Fig. 33 Global chemically defined media market, 2018 - 2030 (USD Million)
  • Fig. 34 Global other cell culture media market, 2018 - 2030 (USD Million)
  • Fig. 35 Global sera market, 2018 - 2030 (USD Million)
  • Fig. 36 Global fetal bovine serum market, 2018 - 2030 (USD Million)
  • Fig. 37 Global others market, 2018 - 2030 (USD Million)
  • Fig. 38 Global reagents market, 2018 - 2030 (USD Million)
  • Fig. 39 Global albumin market, 2018 - 2030 (USD Million)
  • Fig. 40 Global others market, 2018 - 2030 (USD Million)
  • Fig. 41 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 42 Global culture systems market, 2018 - 2030 (USD Million)
  • Fig. 43 Global incubators market, 2018 - 2030 (USD Million)
  • Fig. 44 Global centrifuges market, 2018 - 2030 (USD Million)
  • Fig. 45 Global cryostorage equipment market, 2018 - 2030 (USD Million)
  • Fig. 46 Global biosafety equipment market, 2018 - 2030 (USD Million)
  • Fig. 47 Global pipetting instruments market, 2018 - 2030 (USD Million)
  • Fig. 48 Cell culture market: Application outlook key takeaways
  • Fig. 49 Cell culture market: Application movement analysis
  • Fig. 50 Global biopharmaceutical production market, 2018 - 2030 (USD Million)
  • Fig. 51 Global monoclonal antibodies market, 2018 - 2030 (USD Million)
  • Fig. 52 Global vaccines production market, 2018 - 2030 (USD Million)
  • Fig. 53 Global other therapeutic proteins market, 2018 - 2030 (USD Million)
  • Fig. 54 Global drug development market, 2018 - 2030 (USD Million)
  • Fig. 55 Global diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 56 Global tissue culture & engineering market, 2018 - 2030 (USD Million)
  • Fig. 57 Global cell and gene therapy market, 2018 - 2030 (USD Million)
  • Fig. 58 Global toxicity testing market, 2018 - 2030 (USD Million)
  • Fig. 59 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 60 Regional outlook
  • Fig. 61 Regional marketplace: Key takeaways
  • Fig. 62 North America cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 U.S. cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Canada cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Europe cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 UK cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 France cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Italy cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Spain cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Denmark cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Sweden cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Norway cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Asia Pacific cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Japan cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 China cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 India cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Australia cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Thailand cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Korea cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Brazil cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Mexico cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Argentina cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 MEA cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 South Africa cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Saudi Arabia cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 UAE cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Kuwait cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Market participant categorization
  • Fig. 114 Global cell culture market share analysis, 2022
  • Fig. 115 Strategic framework